These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 28102837)

  • 1. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
    Horii T; Hatada I
    Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient scarless genome editing in human pluripotent stem cells.
    Ikeda K; Uchida N; Nishimura T; White J; Martin RM; Nakauchi H; Sebastiano V; Weinberg KI; Porteus MH
    Nat Methods; 2018 Dec; 15(12):1045-1047. PubMed ID: 30504872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-based Targeted Genome Editing for the Development of Monogenic Diseases Models with Human Pluripotent Stem Cells.
    Gupta N; Susa K; Yoda Y; Bonventre JV; Valerius MT; Morizane R
    Curr Protoc Stem Cell Biol; 2018 May; 45(1):e50. PubMed ID: 30040245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing Point Mutations into Human Pluripotent Stem Cells using Seamless Genome Editing.
    Wang Y; Smith AJH; Hay DC
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Editing in Human Pluripotent Stem Cells.
    Carlson-Stevermer J; Saha K
    Methods Mol Biol; 2017; 1590():165-174. PubMed ID: 28353269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.
    Li HL; Gee P; Ishida K; Hotta A
    Methods; 2016 May; 101():27-35. PubMed ID: 26525194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR Base Editing in Induced Pluripotent Stem Cells.
    Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
    Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for scarless genome editing of human pluripotent stem cell based on orthogonal selective reporters.
    Zhao Y; Pan Z; Hong Z; Sun M; Hong Y; Peng X; Li X; Wang X; Wang K
    STAR Protoc; 2024 Jun; 5(2):103084. PubMed ID: 38787727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
    Merkert S; Martin U
    Adv Biochem Eng Biotechnol; 2018; 163():169-186. PubMed ID: 29124278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Efficient CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
    Maguire JA; Cardenas-Diaz FL; Gadue P; French DL
    Curr Protoc Stem Cell Biol; 2019 Feb; 48(1):e64. PubMed ID: 30358158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Method for Genome Editing in Human Pluripotent Stem Cells.
    Smith C; Ye Z; Cheng L
    Cold Spring Harb Protoc; 2016 Apr; 2016(4):pdb.prot090217. PubMed ID: 27037073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing Using Cas9-gRNA Ribonucleoprotein in Human Pluripotent Stem Cells for Disease Modeling.
    Benetó N; Grinberg D; Vilageliu L; Canals I
    Methods Mol Biol; 2022; 2549():409-425. PubMed ID: 33755903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous reprogramming and gene editing of human fibroblasts.
    Howden SE; Thomson JA; Little MH
    Nat Protoc; 2018 May; 13(5):875-898. PubMed ID: 29622803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.